Allspring Global Investments
KRYS icon

Allspring Global Investments’s Krystal Biotech KRYS Stock Holding History

Allspring Global Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Buy
52,407
+49,932
+2,017% +$14.9M 0.03% 562
2026
Q1 		$641K Buy
2,475
+241
+11% +$64.1K ﹤0.01% 1321
2025
Q4 		$552K Buy
2,234
+185
+9% +$38.9K ﹤0.01% 1347
2025
Q3 		$368K Sell
2,049
-19
-0.9% -$2.84K ﹤0.01% 1424
2025
Q2 		$287K Sell
2,068
-3,112
-60% -$457K ﹤0.01% 1482
2025
Q1 		$904K Sell
5,180
-24,597
-83% -$4.14M ﹤0.01% 1281
2024
Q4 		$4.66M Sell
29,777
-81,928
-73% -$14.5M 0.01% 951
2024
Q3 		$20.3M Sell
111,705
-64,741
-37% -$12.5M 0.03% 558
2024
Q2 		$32.4M Buy
176,446
+18,021
+11% +$3.03M 0.05% 418
2024
Q1 		$28.2M Buy
158,425
+99,101
+167% +$13.8M 0.04% 479
2023
Q4 		$7.36M Buy
59,324
+4,588
+8% +$509K 0.01% 834
2023
Q3 		$6.35M Buy
54,736
+53,606
+4,744% +$6.54M 0.01% 889
2023
Q2 		$133K Buy
1,130
+29
+3% +$2.96K ﹤0.01% 1956
2023
Q1 		$88.1K Buy
1,101
+140
+15% +$11K ﹤0.01% 2093
2022
Q4 		$76.1K Sell
961
-20
-2% -$1.48K ﹤0.01% 2180
2022
Q3 		$68K Buy
981
+709
+261% +$51.2K ﹤0.01% 2231
2022
Q2 		$17K Sell
272
-3,388
-93% -$211K ﹤0.01% 2518
2022
Q1 		$243K Buy
3,660
+376
+11% +$23.5K ﹤0.01% 2507
2021
Q4 		$229K Buy
+3,284
New +$191K ﹤0.01% 2602

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments's KRYS Position: Q2 2026 in Review

Allspring Global Investments increased its Krystal Biotech (KRYS) stake by 2,017% in Q2 2026, buying an estimated $14.9M and bringing the position to 52,407 shares worth $19.5M. The position accounts for 0.03% of the portfolio, ranked #562.

Allspring Global Investments first reported a position in KRYS in Q4 2021 and has held it in 19 quarters since. The position peaked at $32.4M in Q2 2024. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Allspring Global Investments held 52,407 shares of Krystal Biotech worth $19.5M as of Q2 2026.
  • Allspring Global Investments bought 49,932 Krystal Biotech shares in Q2 2026, an estimated $14.9M.
  • Krystal Biotech made up 0.03% of Allspring Global Investments's portfolio in Q2 2026, its #562 holding.
  • Allspring Global Investments first reported a position in Krystal Biotech in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Krystal Biotech position peaked at $32.4M in Q2 2024.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.